Intensive Glycemic Control and Skeletal Health Study

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Treatments: Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents

Criteria

Inclusion criteria:

• Fulfills criteria for inclusion in the ACCORD main trial

• Must have been randomized into the ACCORD study and be a participant from the five CCNs in the ACCORD-BONE ancillary study.

Exclusion criteria:

• Fulfills criteria for exclusion in the ACCORD main trial